Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
South Africa
Pharma
Novo to gradually phase out production of human insulin pens
As sales of Novo Nordisk’s GLP-1 drugs continue to soar, the Danish drugmaker is once again adjusting its insulin production priorities.
Fraiser Kansteiner
Nov 14, 2024 2:13pm
After buyouts, Telix unveils new radiopharma spinoff Rhine
Oct 22, 2024 3:05pm
South Africa drops J&J investigation after Sirturo price cut
Jul 9, 2024 4:25pm
Novo Nordisk taps Aspen to help produce insulin for Africa
Sep 19, 2023 10:16am
Vertex's Trikafta at center of new pricing controversy
Feb 7, 2023 10:59am
Low COVID shot demand is weighing on a Pfizer partner: report
May 12, 2022 1:59pm
